|
ZC3HAV1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.45089999967507E-07 |
| Normal-vs-Stage3 |
3.62959662325579E-11 |
| Normal-vs-Stage4 |
2.55639999946489E-07 |
| Stage1-vs-Stage2 |
3.280800E-01 |
| Stage1-vs-Stage3 |
8.944400E-02 |
| Stage1-vs-Stage4 |
9.234400E-04 |
| Stage2-vs-Stage3 |
7.846600E-01 |
| Stage2-vs-Stage4 |
1.481240E-01 |
| Stage3-vs-Stage4 |
1.663440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.591000E-04 |
| Normal-vs-Asian |
2.288400E-02 |
| Caucasian-vs-AfricanAmerican |
1.821610E-04 |
| Caucasian-vs-Asian |
1.078620E-01 |
| AfricanAmerican-vs-Asian |
5.019600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
6.488200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.797090E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
3.499800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.302800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.166600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.913200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.671400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.616370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.452800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.3673999999918E-05 |
| Normal-vs-Grade 2 |
1.62458935193399E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
4.1267000000067E-05 |
| Grade 1-vs-Grade 2 |
1.268190E-01 |
| Grade 1-vs-Grade 3 |
6.293700E-02 |
| Grade 1-vs-Grade 4 |
6.817000E-03 |
| Grade 2-vs-Grade 3 |
3.570800E-01 |
| Grade 2-vs-Grade 4 |
9.819100E-03 |
| Grade 3-vs-Grade 4 |
5.640300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.95528054752958E-12 |
| ccA subtype-vs-ccB subtype |
5.56990000000201E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
3.296100E-02 |
| N0-vs-N1 |
3.984600E-01 |
|
|
